Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

ChAd-triCoV/Mac

2 clinical trials

1 indication

Indication
COVID-19
Clinical trial
Phase 1, Open Label Study to Evaluate the Safety and Immunogenicity of ChAd68 and AdHu5 Vector-based Trivalent COVID-19 Vaccines Delivered Via Inhaled Aerosol
Status: Active (not recruiting), Estimated PCD: 2024-09-30
Clinical trial
A Phase 2 Trial to Evaluate Safety and Immunogenicity of a Next-generation COVID-19 Vaccine Delivered by Inhaled Aerosol to Humans
Status: Not yet recruiting, Estimated PCD: 2025-07-01